Thirdly, we assessed LC3B cleavage and turnover (LC3B-II) protein levels, which also showed that knocking down LAMP5-AS1 enhanced LC3B-II expression in MLL leukemia cell lines (Fig. 5d and Supplementary Fig. S4b). The gene discussed is KMT2A; the disease is leukemia.